title: Modified allelic replication in lymphocytes of patients with neurofibromatosis type 1.
abstract: Transcription activity of genes is related to their replication timing, accordingly gene activation is coupled with a shift from late replication to early replication and vice versa. The relationship between replication timing and gene expression is best manifested by monoallelically expressed genes which show an asynchronous pattern of allelic replication, with the active allele replicating earlier than the inactive counterpart. Biallelically expressed genes, which normally replicate highly synchronously, when present in lymphocytes derived from patients with various types of malignancies or premalignancies, replicate highly asynchronously, similar to monoallelically expressed genes. Since neurofibromatosis-type 1 (NF1) patients are at an increased risk to develop malignancies, we used the fluorescence in situ hybridization (FISH) replication assay and evaluated the level of replication synchrony of three cancer-implicated genes (RB1, AML1, and CMYC) in lymphocytes derived from patients with NF1 without malignancy. Each gene, which normally displayed synchrony in allelic replication, in the patients' cells displayed loss of synchrony. The loss of replication synchrony, of each gene, in the patients' cells was achieved by an advanced replication of a single allele, which replicated remarkably earlier than its normal scheduled timing. In addition, the second allele showed slightly earlier replication timing than that normal for the gene. Thus, it is assumed that the NF1 condition is associated with activation of cancer-implicated genes that may be the cause for increased risk of patients to develop malignancies. As loss of synchrony in allelic replication timing differentiates well between NF1 patients and control subjects, this marker may have a potential use for identification of presymptomatic carriers of NF1 disorders.
authors.affiliation: Genetic Institute, Assaf Harofeh Medical Center, Zerifin, Israel. oreish@post.tau.ac.il
authors.forename: Orit
authors.initials: O
authors.lastname: Reish
authors.forename: Ana
authors.initials: A
authors.lastname: Orlovski
authors.forename: Maya
authors.initials: M
authors.lastname: Mashevitz
authors.forename: Carron
authors.initials: C
authors.lastname: Sher
authors.forename: Vitalia
authors.initials: V
authors.lastname: Libman
authors.forename: Malka
authors.initials: M
authors.lastname: Rosenblat
authors.forename: Lydia
authors.initials: L
authors.lastname: Avivi
mesh_terms: D000293:Adolescent; D000328:Adult; D000483:Alleles; D002648:Child; D002675:Child, Preschool; D004261:DNA Replication / Q000235:genetics*; D004273:DNA, Neoplasm / Q000235:genetics; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D009456:Neurofibromatosis 1 / Q000235:genetics*; D010835:Phytohemagglutinins / Q000494:pharmacology
chemical_list: D004273:DNA, Neoplasm; D010835:Phytohemagglutinins